Navigation Links
Smallest full support heart assist device on trial at Northwestern Memorial
Date:4/27/2009

CHICAGO - Northwestern Memorial Hospital's Bluhm Cardiovascular Institute is the first center in Chicago and among the first in the country to implant a new experimental left ventricular assist device (LVAD) into subjects with advanced heart failure, a condition where the heart cannot pump enough blood to the body's organs. The HeartWare Ventricular Assist System (HeartWare System) features the HVAD Pump, the smallest LVAD to provide full cardiac support currently under investigation in the United States. The HeartWare System is intended as a bridge to heart transplantation. Northwestern Memorial surgeons have implanted four subjects with the device, and are the first in the country to transplant a subject as part of this trial.

Individuals with advanced heart failure experience symptoms such as swelling, fatigue, shortness of breath and are not able to exert themselves. Medications are often successful for managing symptoms in the earlier stages of heart failure, but for patients in the late-stages heart transplantation is considered the best treatment option. However, with just over 2,000 donor hearts becoming available each year, the wait for a transplant can be long. The smaller model is being studied as a less cumbersome LVAD procedure in subjects with advanced-stage heart failure who need support to survive until a donor heart becomes available. In subsequent trials the HVAD Pump will be trialed in subjects that are not transplant candidates.

Edwin McGee Jr., MD, the principal investigator of the trial, cardiac surgeon and the surgical director of Heart Transplantation and Mechanical Assistance at the Bluhm Cardiovascular Institute, lead the team that implanted the four subjects. The national clinical trial hopes to enroll up to 150 subjects. Twenty-two subjects have been enrolled in the U.S to date.

"The small size and unique configuration of this particular model allows us to place it adjacent to the ventricle itself, as opposed to implanting the device in the abdominal wall," commented Dr. McGee. "This is a major step forward, as it is intended to reduce the potential risks associated with a more extensive surgery such as bleeding and infections. We are also able to cast a wider net of potential subjects and can include more women in the trials since the device is significantly smaller than previous models."

The device is a tiny centrifugal blood pump, with a levitating impeller that spins to continuously move blood from the heart to the rest of the body. A driveline cable attaches to the pump and connects to a portable controller, powered by a pair of battery packs, worn by the subject allowing for mobility.

According to the American Heart Association, 4.9 million patients in the United States suffer from heart failure, with an additional 550,000 diagnosed each year. The National Institutes of Health estimates that in the US, approximately 100,000 patients per year could benefit from an LVAD.

"Heart failure is a growing epidemic in this country and we hope that this trial will lead to better outcomes and fewer complications for patients with severe heart failure," said Dr. McGee. This LVAD is the next step in the evolution of heart assist devices, which, in the future, could result in a fully-implantable model.


'/>"/>

Contact: Amy Dobrozsi
adobrozs@nmh.org
312-926-5900
Northwestern Memorial Hospital
Source:Eurekalert

Related medicine news :

1. VIDEO from Medialink and Abiomed: Worlds Smallest Heart Pump Receives 510(K) Clearance from FDA
2. LightAir Cleans the Air From the Smallest and Most Dangerous Particles Without Generating Ozone
3. Smallest Air Pollution Particles Hurt Heart Most
4. VIDEO from Medialink and Siemens: Worlds Smallest Ultrasound Package Launches in the U.S.
5. Good Imaging Now Comes in the Worlds Smallest Ultrasound Package
6. Medicare Offers Smallest Rise in Premiums in 6 Years
7. Thermal Angel Supports Infection Control During the Golden Hour
8. Teamsters, Area Unions Rally in Support of Rural/Metro Workers
9. Cardinal Rigali Praises House Re-Introduction of Pregnant Women Support Act, Urges Co-Sponsorship
10. New Evidence Supports Efficacy and Value of Smith & Nephew NPWT Products
11. Wounded Warrior Project (WWP) Announces Support for Soldier Ride from Boston Scientific
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... ... The Lung Institute has partnered with the Gulfcoast North Area ... at their clinic in downtown Tampa. The class is complimentary for the public. Register ... a free downloadable 4 Week Smoking Cessation Guide for those who are ...
(Date:5/26/2016)... ... 26, 2016 , ... American orthopedic surgeon and internationally recognized ... Horizon International (BHI), Brian Mehling, M.D., spoke at an International Conference and Expo ... in Chicago, IL, USA. Dr. Mehling’s presentation was focused on stem cell therapy ...
(Date:5/26/2016)... TN (PRWEB) , ... May 26, 2016 , ... ... fitness education and products recently hosted the first PowerWave Instructor Certification Course in ... who lead a group of fitness professional through the 8 hour interactive course ...
(Date:5/26/2016)... ... 2016 , ... On May 23rd during the National Eye Institute’s “Healthy Vision ... advocate, was honored by Ashram, Inc. as the world’s foremost water visionary. , “Sharon ... banks of the Nile to fill their red clay pots with life-sustaining water.” Said ...
(Date:5/26/2016)... ... May 26, 2016 , ... Workrite Ergonomics ... leadership and to further develop their rapidly expanding portfolio of customer and end ... a concentration in Marketing and an M.B.A. with concentration in management from Bryant ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... , May 26, 2016 ... Associated With Both Cost Savings and Overall ... plc (LSE: BTG), an international specialist healthcare company, ... at the 21st Annual Meeting of ISPOR (International ... treatment of hepatocellular carcinoma (HCC) using yttrium-90 glass ...
(Date:5/25/2016)... FDA 510(k) clearance covers ... for urological and surgical applications Mauna ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, ... US with the 12 th 510(k) clearance ... This new FDA clearance covers Confocal Miniprobes indicated ...
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, 2016 /PRNewswire/ ... Frankfurt Prime Standard: QIA) today announced that the company has ... GmbH to develop and commercialize predictive assays in oncology. An ... a marker to predict effectiveness of anthracycline treatment in triple ... are pleased to partner with Therawis, which developed the PITX2 ...
Breaking Medicine Technology: